These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25269800)

  • 21. [Down's syndrome and dementia: a growing problem in the care of the mentally retarded].
    Evenhuis HM; van der Stal H
    Ned Tijdschr Geneeskd; 1988 Aug; 132(33):1513-6. PubMed ID: 2971882
    [No Abstract]   [Full Text] [Related]  

  • 22. [Siccacell therapy in Down's syndrome].
    Armoni M; Schlesinger M; Levin S
    Harefuah; 1985 Jan; 108(2):64-8. PubMed ID: 3158577
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter: Institutionalization of children with Down's syndrome].
    Engbaek S
    Ugeskr Laeger; 1976 Jun; 138(25):1544-5. PubMed ID: 132728
    [No Abstract]   [Full Text] [Related]  

  • 24. Zinc may be a double-faced Janus to Down's syndrome patients.
    Zatta P
    Biol Trace Elem Res; 2000 Jan; 73(1):93-4. PubMed ID: 10949973
    [No Abstract]   [Full Text] [Related]  

  • 25. Congenital heart defects are under-recognised in adult patients with Down's syndrome.
    Vis JC; de Bruin-Bon RH; Bouma BJ; Huisman SA; Imschoot L; van den Brink K; Mulder BJ
    Heart; 2010 Sep; 96(18):1480-4. PubMed ID: 20643661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down's syndrome treated with a low phenylalanine diet: case report.
    Marsh RW; Cabaret JJ
    N Z Med J; 1972 Jun; 75(481):364-5. PubMed ID: 4264114
    [No Abstract]   [Full Text] [Related]  

  • 27. [Program of early stimulation: fixing the attention of (mongolian) children with Down's syndrome].
    Santos E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(2):83-90. PubMed ID: 2932893
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parents of people with Down's syndrome report suboptimal care.
    Mayor S
    BMJ; 1999 Mar; 318(7185):687. PubMed ID: 10073997
    [No Abstract]   [Full Text] [Related]  

  • 31. [Speech rehabilitation in children with Down's syndrome].
    Betlejewski S; Klajman S; Novak A; Walczyński Z
    Pediatr Pol; 1970 Feb; 45(2):201-3. PubMed ID: 4245095
    [No Abstract]   [Full Text] [Related]  

  • 32. [Letter: Comment on therapy of Down's syndrome from the cytogenetic and clinical viewpoints].
    Pfeiffer RA
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):678-83. PubMed ID: 126372
    [No Abstract]   [Full Text] [Related]  

  • 33. Cognitive deficits and associated neurological complications in individuals with Down's syndrome.
    Lott IT; Dierssen M
    Lancet Neurol; 2010 Jun; 9(6):623-33. PubMed ID: 20494326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Data on glutamic acid therapy of oligophrenia in childhood with special reference to Down's disease].
    GOLLESZ V
    Gyermekgyogyaszat; 1960 Nov; 11():340-4. PubMed ID: 13706714
    [No Abstract]   [Full Text] [Related]  

  • 35. Experience in counselling Down's syndrome.
    Garg P
    Indian Pediatr; 2007 Aug; 44(8):623. PubMed ID: 17827643
    [No Abstract]   [Full Text] [Related]  

  • 36. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denying treatment to Down's syndrome children.
    Keenan P; McIntosh P
    Prof Care Mother Child; 1999; 9(5):133. PubMed ID: 10818954
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antigenic treatment of patients with Down's syndrome].
    Ruiz-Castañeda M; Gutiérrez de Velásco-Hernández C; Gómez-Ortiz ME; Pillado-Hernández MT
    Bol Med Hosp Infant Mex; 1982 Dec; 39(12):778-80. PubMed ID: 6220726
    [No Abstract]   [Full Text] [Related]  

  • 40. [Letter: Comment on therapy of Down's syndrome, especially on cell therapy from the neurophysiological/neuropediatric viewpoint].
    Schulte FJ
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):683-5. PubMed ID: 126373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.